Ann D. Rhoads's most recent trade in QuidelOrtho Corporation was a trade of 6,829 Restricted Stock Units (Equity Grant) done . Disclosure was reported to the exchange on May 29, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| QuidelOrtho Corporation | Ann D. Rhoads | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 6,829 | 6,829 | - | - | Restricted Stock Units (Equity Grant) | |
| QuidelOrtho Corporation | Ann D. Rhoads | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 6,829 | 6,829 | - | - | Restricted Stock Units (Equity Grant) | |
| QuidelOrtho Corporation | Ann D. Rhoads | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 1,626 | 1,626 | - | - | Restricted Stock Units (Converted) | |
| QuidelOrtho Corporation | Ann D. Rhoads | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 1,626 | 1,626 | - | - | Restricted Stock Units (Converted) | |
| QuidelOrtho Corporation | Ann D. Rhoads | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 325 | 325 | - | - | Restricted Stock Units (Premium) | |
| QuidelOrtho Corporation | Ann D. Rhoads | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 325 | 325 | - | - | Restricted Stock Units (Premium) | |
| QuidelOrtho Corporation | Ann D. Rhoads | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 May 2025 | 546 | 0 | - | - | Restricted Stock Units (Converted) | |
| QuidelOrtho Corporation | Ann D. Rhoads | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2025 | 546 | 14,162 (0%) | 0% | 0 | Common Stock | |
| QuidelOrtho Corporation | Ann D. Rhoads | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 May 2025 | 109 | 0 | - | - | Restricted Stock Units (Premium) | |
| QuidelOrtho Corporation | Ann D. Rhoads | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2025 | 109 | 14,271 (0%) | 0% | 0 | Common Stock | |
| QuidelOrtho Corporation | Ann D. Rhoads | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 May 2025 | 4,929 | 0 | - | - | Restricted Stock Units (Equity Grant) | |
| QuidelOrtho Corporation | Ann D. Rhoads | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2025 | 4,929 | 13,616 (0%) | 0% | 0 | Common Stock | |
| QuidelOrtho Corporation | Ann D. Rhoads | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 May 2025 | 427 | 0 | - | - | Restricted Stock Units (Converted) | |
| QuidelOrtho Corporation | Ann D. Rhoads | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2025 | 427 | 8,559 (0%) | 0% | 0 | Common Stock | |
| QuidelOrtho Corporation | Ann D. Rhoads | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2025 | 128 | 8,687 (0%) | 0% | 0 | Common Stock | |
| QuidelOrtho Corporation | Ann D. Rhoads | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 May 2025 | 128 | 0 | - | - | Restricted Stock Units (Premium ) | |
| Globus Medical Inc - Ordin... | Ann D. Rhoads | Director | Sale of securities on an exchange or to another person at price $ 78.68 per share. | 28 Feb 2025 | 7,500 | 35,384 (0%) | 0% | 78.7 | 590,100 | Class A Common Stock |
| Globus Medical Inc - Ordin... | Ann D. Rhoads | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2025 | 15,000 | 15,000 | - | - | Stock Option (Right to Buy Class A Common Stock) | |
| Globus Medical Inc - Ordin... | Ann D. Rhoads | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Sep 2024 | 20,000 | 0 | - | - | Stock Option (Right to Buy Class A Common Stock) | |
| Globus Medical Inc - Ordin... | Ann D. Rhoads | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 25.52 per share. | 13 Sep 2024 | 20,000 | 57,884 (0%) | 0% | 25.5 | 510,400 | Class A Common Stock |
| Globus Medical Inc - Ordin... | Ann D. Rhoads | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 24.10 per share. | 13 Sep 2024 | 15,000 | 37,884 (0%) | 0% | 24.1 | 361,500 | Class A Common Stock |
| Globus Medical Inc - Ordin... | Ann D. Rhoads | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Sep 2024 | 15,000 | 0 | - | - | Stock Option (Right to Buy Class A Common Stock) | |
| Globus Medical Inc - Ordin... | Ann D. Rhoads | Director | Sale of securities on an exchange or to another person at price $ 70.36 per share. | 13 Sep 2024 | 15,000 | 42,884 (0%) | 0% | 70.4 | 1,055,400 | Class A Common Stock |
| Repare Therapeutics Inc | Ann D. Rhoads | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2024 | 27,200 | 27,200 | - | - | Stock Option (right to buy) | |
| ITeos Therapeutics Inc | Ann D. Rhoads | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2024 | 24,200 | 24,200 | - | - | Stock Option (Right to Buy) | |
| QuidelOrtho Corporation | Ann D. Rhoads | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 1,017 | 7,929 (0%) | 0% | 0 | Common Stock | |
| QuidelOrtho Corporation | Ann D. Rhoads | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jun 2024 | 1,017 | 0 | - | - | Restricted Stock Units (Converted) | |
| QuidelOrtho Corporation | Ann D. Rhoads | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jun 2024 | 203 | 0 | - | - | Restricted Stock (Premium) | |
| QuidelOrtho Corporation | Ann D. Rhoads | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 203 | 8,132 (0%) | 0% | 0 | Common Stock | |
| QuidelOrtho Corporation | Ann D. Rhoads | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2024 | 2,416 | 6,912 (0%) | 0% | 0 | Common Stock | |
| QuidelOrtho Corporation | Ann D. Rhoads | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 May 2024 | 2,416 | 0 | - | - | Restricted Stock Units (Equity Grant) | |
| QuidelOrtho Corporation | Ann D. Rhoads | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2024 | 4,929 | 4,929 | - | - | Restricted Stock Units (Equity Grant) | |
| QuidelOrtho Corporation | Ann D. Rhoads | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2024 | 1,173 | 1,173 | - | - | Restricted Stock Units (Converted) | |
| QuidelOrtho Corporation | Ann D. Rhoads | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2024 | 234 | 234 | - | - | Restricted Stock Units (Premium) | |
| Globus Medical Inc - Ordin... | Ann D. Rhoads | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2024 | 15,000 | 15,000 | - | - | Stock Option (Right to Buy Class A Common Stock) | |
| ITeos Therapeutics Inc | Ann D. Rhoads | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2023 | 22,383 | 22,383 | - | - | Stock Option (Right to Buy) | |
| Repare Therapeutics Inc | Ann D. Rhoads | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 27,200 | 27,200 | - | - | Stock Option (right to buy) | |
| QuidelOrtho Corporation | Ann D. Rhoads | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2023 | 2,248 | 4,496 (0%) | 0% | 0 | Common Stock | |
| QuidelOrtho Corporation | Ann D. Rhoads | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jun 2023 | 2,248 | 0 | - | - | Restricted Stock Units (Equity Grant) | |
| QuidelOrtho Corporation | Ann D. Rhoads | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2023 | 2,416 | 2,416 | - | - | Restricted Stock Units (Equity Grant) | |
| QuidelOrtho Corporation | Ann D. Rhoads | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2023 | 546 | 546 | - | - | Restricted Stock Units (Converted) | |
| QuidelOrtho Corporation | Ann D. Rhoads | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2023 | 109 | 109 | - | - | Restricted Stock Units (Premium) | |
| Globus Medical Inc - Ordin... | Ann D. Rhoads | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jan 2023 | 7,500 | 0 | - | - | Stock Option (Right to Buy Class A Common Stock) | |
| Globus Medical Inc - Ordin... | Ann D. Rhoads | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.59 per share. | 27 Jan 2023 | 7,500 | 22,884 (0%) | 0% | 12.6 | 94,425 | Class A Common Stock |
| Globus Medical Inc - Ordin... | Ann D. Rhoads | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2023 | 15,000 | 15,000 | - | - | Stock Option (Right to Buy Class A Common Stock) | |
| QuidelOrtho Corporation | Ann D. Rhoads | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2022 | 2,248 | 2,248 | - | - | Restricted Stock Units (Equity Grant) | |
| QuidelOrtho Corporation | Ann D. Rhoads | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2022 | 1,017 | 1,017 | - | - | Restricted Stock Units (Converted) | |
| QuidelOrtho Corporation | Ann D. Rhoads | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2022 | 203 | 203 | - | - | Restricted Stock Units (Premium) | |
| QuidelOrtho Corporation | Ann D. Rhoads | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2022 | 2,248 | 2,248 (0%) | 0% | - | Common Stock | |
| QuidelOrtho Corporation | Ann D. Rhoads | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 27 May 2022 | 2,248 | 0 (0%) | 0% | - | Common Stock | |
| QuidelOrtho Corporation | Ann D. Rhoads | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 27 May 2022 | 427 | 0 | - | - | Restricted Stock Units | |
| QuidelOrtho Corporation | Ann D. Rhoads | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2022 | 427 | 427 | - | - | Restricted Stock Units | |
| QuidelOrtho Corporation | Ann D. Rhoads | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2022 | 128 | 128 | - | - | Restricted Stock Units | |
| QuidelOrtho Corporation | Ann D. Rhoads | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 27 May 2022 | 128 | 0 | - | - | Restricted Stock Units | |
| Repare Therapeutics Inc | Ann D. Rhoads | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2022 | 49,000 | 49,000 | - | - | Stock Option (right to buy) | |
| Globus Medical Inc - Ordin... | Ann D. Rhoads | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2022 | 15,000 | 15,000 | - | - | Stock Option (Right to Buy Class A Common Stock) | |
| ITeos Therapeutics Inc | Ann D. Rhoads | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2021 | 16,608 | 16,608 | - | - | Stock Option (Right to Buy) | |
| QuidelOrtho Corporation | Ann D. Rhoads | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2021 | 1,624 | 1,624 | - | - | Restricted Stock Units (Equity Grant) | |
| QuidelOrtho Corporation | Ann D. Rhoads | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2021 | 427 | 427 | - | - | Restricted Stock Units (Converted) | |
| QuidelOrtho Corporation | Ann D. Rhoads | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2021 | 128 | 128 | - | - | Restricted Stock Units (Premium) | |
| Repare Therapeutics Inc | Ann D. Rhoads | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2021 | 21,000 | 21,000 | - | - | Stock Option (right to buy) | |
| Globus Medical Inc - Ordin... | Ann D. Rhoads | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.66 per share. | 01 Mar 2021 | 15,384 | 15,384 (0%) | 0% | 10.7 | 163,993 | Class A Common Stock |
| Globus Medical Inc - Ordin... | Ann D. Rhoads | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2021 | 15,384 | 0 | - | - | Stock Option (Right to Buy Class A Common Stock) | |
| Globus Medical Inc - Ordin... | Ann D. Rhoads | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jan 2021 | 15,000 | 15,000 | - | - | Stock Option (Right to Buy Class A Common Stock) | |
| QuidelOrtho Corporation | Ann D. Rhoads | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Aug 2020 | 624 | 624 | - | - | Restricted Stock Units | |
| ITeos Therapeutics Inc | Ann D. Rhoads | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jul 2020 | 16,608 | 0 | - | - | Stock Option (Right to Buy) |